What is the share price of Remus Pharmaceuticals Ltd (REMUS) today?

The share price of REMUS as on 18th September 2026 is ₹979.05. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on Remus Pharmaceuticals Ltd (REMUS) share?

The past returns of Remus Pharmaceuticals Ltd (REMUS) share are Past 1 week: 11.13%Past 1 month: 8.30%Past 3 months: 18.31%Past 6 months: 49.99%Past 1 year: 23.00%Past 3 years: 78.41%Past 5 years: 335.91%

What are the peers or stocks similar to Remus Pharmaceuticals Ltd (REMUS)?

The peers or stocks similar to Remus Pharmaceuticals Ltd (REMUS) include: Remus Pharmaceuticals Ltd Sun Pharmaceutical Industries Ltd Torrent Pharmaceuticals Ltd Zydus Lifesciences Ltd Cipla Ltd Laurus Labs Ltd

What is the dividend yield % of Remus Pharmaceuticals Ltd (REMUS) share?

The current dividend yield of Remus Pharmaceuticals Ltd (REMUS) is 0.05.

What is the market cap of Remus Pharmaceuticals Ltd (REMUS) share?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Remus Pharmaceuticals Ltd (REMUS) is ₹1153.71 Cr as of 18th September 2026.

What is the 52 week high and low of Remus Pharmaceuticals Ltd (REMUS) share?

The 52-week high of Remus Pharmaceuticals Ltd (REMUS) is ₹1007 and the 52-week low is ₹580.

What is the PE and PB ratio of Remus Pharmaceuticals Ltd (REMUS) stock?

The P/E (price-to-earnings) ratio of Remus Pharmaceuticals Ltd (REMUS) is 31.19. The P/B (price-to-book) ratio is 4.08.

Which sector does Remus Pharmaceuticals Ltd (REMUS) belong to?

Remus Pharmaceuticals Ltd (REMUS) belongs to the Health Care sector & Pharmaceuticals sub-sector.

How to buy Remus Pharmaceuticals Ltd (REMUS) shares?

You can directly buy Remus Pharmaceuticals Ltd (REMUS) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Remus Pharmaceuticals Ltd

REMUS Share Price

NSE

₹979.050.60% (-5.95)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹1,153 cr, stock is ranked 1,547

High Risk

Stock is 4.11x as volatile as Nifty

REMUS Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹1,153 cr, stock is ranked 1,547

High Risk

Stock is 4.11x as volatile as Nifty

REMUS Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
—	4.08	0.05%

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
47.20	5.92	0.48%

REMUS Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

REMUS Company Profile

Remus Pharmaceuticals Ltd markets and distributes pharmaceutical formulations and active pharmaceutical ingredients, specializing in various therapeutic areas including oncology and cardiovascular health.

REMUS Similar Stocks (Peers)

Compare with peers Compare with peers

REMUS Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

38.40

1Y Return

11.45%

Buy Reco %

93.33

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

85.10

1Y Return

35.67%

Buy Reco %

81.48

Zydus Lifesciences Ltd

ZYDUSLIFE

PE Ratio

22.96

1Y Return

10.70%

Buy Reco %

55.56

Cipla Ltd

CIPLA

PE Ratio

29.04

1Y Return

11.64%

Buy Reco %

62.86

Laurus Labs Ltd

LAURUSLABS

PE Ratio

118.79

1Y Return

111.64%

Buy Reco %

58.33

Compare with Peers

REMUS Forecast

REMUS Forecasts

REMUS

Income

Balance Sheet

Cash Flow

Financial Year		FY 2024		FY 2025	FY 2026	TTM
Total Revenue	215.77	625.34	860.33	0.00
Raw Materials	164.14	541.31	796.94	0.00
Power & Fuel Cost	0.01	0.06
Employee Cost	7.32	13.11
Selling & Administrative Expenses	8.36	19.19
Operating & Other expenses	4.15	1.00
EBITDA	31.79	50.67	63.39	0.00
Depreciation/Amortization	1.12	1.87	2.76	0.00
PBIT	30.67	48.80	60.63	0.00
Interest & Other Items	0.50	1.46	1.47	0.00
PBT	30.17	47.34	59.16	0.00
Taxes & Other Items	9.65	18.27	22.17	0.00
Net Income	20.52	29.07	36.99	0.00
EPS	17.41	24.67	39.19	0.00
DPS	0.75	0.75	0.50	0.00
Payout ratio	0.04	0.03	0.01	0.00

REMUS Income Statement

Hmm, looks like data is unavailable here. Please come back after some time

Financial Year		FY 2024	FY 2025
Cash from Operating Activities	3.60	6.99
Cash from Investing Activities	-8.94	-10.55
Cash from Financing Activities	24.37	6.07
Net Change in Cash	+19.03	+2.51
Changes in Working Capital	-27.45	-40.58
Capital Expenditures	0.72	3.98
Free Cash Flow	2.88	3.01

REMUS Company Updates

REMUS Stock Peers

REMUS Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Remus Pharmaceuticals Ltd	31.19	4.08	0.05%
Sun Pharmaceutical Industries Ltd	38.40	5.26	0.87%
Torrent Pharmaceuticals Ltd	85.10	10.47	0.70%
Zydus Lifesciences Ltd	22.96	3.91	0.09%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
Remus Pharmaceuticals Ltd	Pro
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Remus Pharmaceuticals Ltd	54.58%	58.04	Pro
Sun Pharmaceutical Industries Ltd	20.14%	35.35
Torrent Pharmaceuticals Ltd	22.47%	35.75
Zydus Lifesciences Ltd	23.98%	43.61

REMUS Stock Price Comparison

Compare REMUS with any stock or ETF

REMUS

REMUS Holdings

REMUS Shareholdings

REMUS Promoter Holdings Trend

REMUS Institutional Holdings Trend

No institutional holdings trend are available

REMUS Shareholding Pattern

REMUS Shareholding History

Foreign Institutions

REMUS Insider Trades & Bulk Stock Deals

smallcases containing REMUS stock

Looks like this stock is not in any smallcase yet.

REMUS Events

REMUS Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

REMUS Dividend Trend

No dividend trend available

REMUS Upcoming Dividends

No upcoming dividends are available

REMUS Past Dividends

Cash Dividend

Ex DateEx DateNov 14, 2025

Interim 1

Interim 1 | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Nov 14, 2025

Cash Dividend

Ex DateEx DateSep 18, 2025

Final

Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 18, 2025

Cash Dividend

Ex DateEx DateNov 19, 2024

Interim

Interim | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Nov 19, 2024

Cash Dividend

Ex DateEx DateMay 2, 2024

Interim 2

Interim 2 | Div/Share: ₹4.00

Dividend/Share

₹4.00

Ex DateEx Date

May 2, 2024

Cash Dividend

Ex DateEx DateOct 27, 2023

Interim

Interim | Div/Share: ₹2.00

Dividend/Share

₹2.00

Ex DateEx Date

Oct 27, 2023

No upcoming corporate actions are available

Bonus

Ex DateEx DateJul 4, 2025

1:1 Bonus Issue of Equity Shares

1:1 Bonus Issue of Equity Shares | Ratio: 1:1

Ratio

1:1

Ex DateEx Date

Jul 4, 2025

Bonus

Ex DateEx DateJun 6, 2024

3:1 Bonus Issue of Equity Shares

3:1 Bonus Issue of Equity Shares | Ratio: 3:1

Ratio

3:1

Ex DateEx Date

Jun 6, 2024

REMUS Announcements

Hmm, looks like data is unavailable here. Please come back after some time

REMUS Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

REMUS Stock News & Opinions

Corporate

Board of Remus Pharmaceuticals recommends final dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 20 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.

4 months agoCapital Market - Live

Corporate

Remus Pharmaceuticals to announce Quarterly Result

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2026.

4 months agoCapital Market - Live

Corporate

Board of Remus Pharmaceuticals recommends First Interim Dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 10 November 2025, has recommended a First Interim Dividend of Rs.0.50 per share (i.e.0.05), subject to the approval of the shareholders.Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 November 2025.Powered by Capital Market - Live

10 months agoCapital Market - Live

Corporate

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 10th Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live